For many cancers, it was suggested that P-bodies contribute to the activation of pro-tumoral pathways (e.g., MAPK, RAS (GTPase-activating protein-binding protein 1), Wnt or AKT signaling), thereby promoting cancer cell proliferation and invasion, while hindering cell death [41]. The gene discussed is AKT1; the disease is cancer.